Abstract
Studies investigating mechanisms of mucociliary clearance have suggested that β 2-adrenergic agents may significantly influence ciliary activity of epithelial cells and therefore play a vital role in the maintenance of functional integrity of the airways. We have cultured human bronchial epithelial cells, from surgical explants and investigated the effects of salbutamol and salmeterol, in a time- and dose-dependent manner, on the ciliary beat frequency (CBF) of these cells. Prior to and at several times after exposure to either salbutamol (10 −8 to 10 −3 m) or salmeterol (10 −8 to 10 −4 m), the epithelial cells were monitored for CBF and on the basis of data obtained from these studies, the effect of 10 −6 m propranolol was investigated in the presence of optimal concentrations of salbutamol and salmeterol. Salbutamol was optimally active at a concentration of 10 −4 m and caused a transient but significant increase in the CBF from baseline level of 8.6 ± 0.4 to 9.6 ± 0.5 Hz ( P < 0.05), after 2 h incubation. In contrast, salmeterol was maximally active at a concentration of 10 −6 m and caused a significantly rapid and prolonged increase in CBF from a baseline value of 9.2 ± 0.4 to 10.9 ± 0.6 Hz ( P < 0.02) and 10.6 ± 0.8 Hz ( P < 0.05) after 15 min and 24 h incubation, respectively. Propranolol (10 −6 m) abrogated the salbutamol- but not the salmeterol-induced increases in CBF. Analysis of cultures for cAMP demonstrated that both salbutamol and salmeterol led to a significant release of cAMP into the culture medium and increased the amounts of CAMP from a baseline value of 4.5 ± 0.7 fmol/μg protein to 137.4 ± 38.7 and 151.8 ± 49.1 fmol/μg protein, respectively, after 24 h incubation ( P < 0.001). Propranolol significantly attenuated both the salbutamol- and salmeterol-induced release of cAMP ( P < 0.001 and P < 0.01, respectively). These results suggest that salmeterol may be of particular significance in the management of airway disease due to its role in mucociliary clearance, in addition to bronchodilation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.